Alkermes ALKS
NASDAQ ALKS
$45.43 -0.06 (-0.13%)
As of: Sep 9, 2026 · 1:23 PM EDT

Alkermes (ALKS) Interest Expenses (2010 - 2026)

Alkermes' (ALKS) quarterly Interest Expenses came in at $25.9 million in Q2 2026, up 24.09% quarter-over-quarter from $20.9 million in Q1 2026.

Analysis

Alkermes (ALKS) Interest Expenses (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Interest Expenses for 17 consecutive years, with $25.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Interest Expenses changed N/A year-over-year to $25.9 million in Q2 2026; TTM through Jun 2026 was $59.1 million, a 454.98% increase from a year earlier, with the FY2025 full-year figure at $12.3 million, down 45.62% from the prior year.
  • Interest Expenses was $25.9 million for Q2 2026 at Alkermes, up from $20.9 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $25.9 million in Q2 2026 and troughed at $2.4 million in Q1 2022.
  • A 5-year average of $7.8 million and a median of $6.0 million in 2024 frame the typical range for Interest Expenses.
  • Across the five-year window, Interest Expenses plunged 40.81% in 2022 and surged 164.14% in 2025, its largest moves.
  • Over 5 years, Interest Expenses stood at $4.8 million in 2022, then rose by 26.94% to $6.1 million in 2023, then decreased by 23.22% to $4.6 million in 2024, then soared by 164.14% to $12.3 million in 2025, then jumped by 111.17% to $25.9 million in 2026.
  • The last three Interest Expenses figures came in at $25.9 million (Q2 2026), $20.9 million (Q1 2026), and $12.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn 281.00 Mn
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn -
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -462.00 Mn
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn -
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 44.21 Bn 44.21 Bn - 23.78 Mn
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn 2.90 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn 25.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.93 Mn
Mar 31, 2026 20.89 Mn
Dec 31, 2025 12.28 Mn
Dec 31, 2024 4.65 Mn
Sep 30, 2024 6.00 Mn
Jun 30, 2024 5.95 Mn
Mar 31, 2024 5.98 Mn
Dec 31, 2023 6.05 Mn
Sep 30, 2023 6.01 Mn
Jun 30, 2023 5.68 Mn
Mar 31, 2023 5.29 Mn
Dec 31, 2022 4.77 Mn
Sep 30, 2022 3.55 Mn
Jun 30, 2022 2.37 Mn
Mar 31, 2022 2.35 Mn
Dec 31, 2021 2.41 Mn
Sep 30, 2021 2.44 Mn
Jun 30, 2021 2.41 Mn
Mar 31, 2021 3.97 Mn
Dec 31, 2020 1.87 Mn